Key result
T2DM linked to ~250% higher MACE risk after PCI in dysfunctional myocardium.
Why the study?
The features of endovascular intervention and factors affecting delayed treatment outcomes in patients with left ventricular dysfunctional myocardium and concomitant type 2 diabetes mellitus were not well characterized.
Cohort (n=214)
Yes
Warrants caution in T2DM patients with dysfunctional myocardium post-PCI; leaves open whether targeted interventions reduce MACE.
Aim. Study of the features of endovascular intervention, correction of the lipid and carbohydrate metabolism as well as the role of myocardial visualization methods and their effect on delayed results of treatment of patients with left ventricular dysfunctional myocardium and concomitant diabetes mellitus. Methods. The analysis of the treatment results of patients with dysfunctional myocardium and concomitant diabetes mellitus type 2 was performed. The analysis included 112 patients. The comparison group included 102 patients without diabetes. Visualization of postinfarction myocardial changes was performed with the use of magnetic resinance imaging of the heart both before and after the assessment of the delayed results. Results. After 18-months follow-up mortality from cardiovascular comlications as well as the rate of major cardiac events was similar to that among patients without diabetes (1.8 and 1%; 6.25 and 3.92%, respectively). The similar tendency was observed 24 months after the intervention (3.3 and 2.3%; 9.8 and 5.7%, respectively). Among the factors associated with the development of such complications are preoperative values of glycosylated hemoglobin ≥6.5%, fasting plasm level of glucose ≥6.0 mmol/l, total cholesterol ≥5.2%, triglycerides ≥1,7 mmol/l, low-density lipoproteins ≥2.5 mmol/l. Also percutaneous coronary intervention later than 30 days after the myocardial infarction and incomplete myocardial revascularization, SYNTAX score >25, transmurality index ≥0.45, cardiac fibrosis ≥45% and presence of diabetes mellitus were prognostically unfavorable risk factors of cardiovascular events. Conclusion. In patients with left ventricular dysfunctional myocardium and concomitant diabetes mellitus higher efficacy of endivascular intervention was observed and the prevalence of major cardiac events was camparable to the patients without diabetes; delayed percutaneous coronary intervention, incomplete myocardial revascularization, high indices of transmurality and cardiac fibrosis are prognostically unfavorable risk factors of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Rustamova et al. (2019) conducted a cohort in Left ventricular dysfunctional myocardium and multivessel coronary artery disease (n=214). Type 2 diabetes mellitus vs. No diabetes was evaluated on Major adverse cardiovascular events at 24 months (OR 3.48, 95% CI 1.59-7.88, p=<0.001). Type 2 diabetes mellitus significantly increased the risk of major adverse cardiovascular events at 24 months in patients with dysfunctional myocardium undergoing percutaneous coronary intervention (OR 3.48).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: